Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of the Male Reproductive SystemDRG 717-other-male-reproductive-system-o-r-procedures-except-malignancy-with-cc-mcc
    Ask Trek AI about this page

    Other Male Reproductive System O.R. Procedures Except Malignancy with CC/MCC: Inpatient Reimbursement Overview

    DRG 717 encompasses other male reproductive system operating room procedures for non-malignant conditions when a Major Complication or Comorbidity or a Complication or Comorbidity is present, affecting resource intensity and coding assignment. It matters for inpatient reimbursement because proper coding and documentation determine prospective payment classification and hospital payment for higher-acuity surgical encounters.

    Customize your policy alerts

    Sign up for drg 717 policy alerts

    Get alerted when payer policies referencing 717 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 717 Overview

    DRG 717 covers other male reproductive system operating room procedures for non-malignant conditions when a Major Complication or Comorbidity or a Complication or Comorbidity is present. Typical cases include complex procedures on the prostate, scrotum, testes, or penis that require inpatient surgical care and additional resources due to comorbid conditions or complications. This Diagnosis-Related Group matters for Medicare payment because it groups similar clinical resource use for prospective payment and affects reimbursement levels for hospitals treating these higher-acuity surgical patients. Accurate documentation of diagnoses, procedures, and comorbidities drives correct assignment to this Diagnosis-Related Group.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Trials assessing perioperative management strategies for non-malignant male reproductive surgeries (for example, studies comparing regional versus general anesthesia protocols, or enhanced recovery after surgery bundles) that enroll adult men undergoing procedures such as transurethral resections for benign prostatic hyperplasia, vasovasostomy, or corrective scrotal surgeries. These studies focus on intra- and immediate postoperative complications, pain control, and length of stay, addressing how procedural and anesthetic choices impact short-term morbidity. Findings are directly relevant to clinicians optimizing care pathways and to payers because reductions in complications and hospital days can lower DRG-related costs.
    • Comparative effectiveness studies of surgical techniques and minimally invasive approaches for benign conditions of the male reproductive tract, enrolling men across age and comorbidity strata to compare outcomes between open, endoscopic, and laparoscopic/robotic procedures. These trials measure functional outcomes (urinary function, fertility implications when applicable), reoperation rates, and resource utilization over 30–90 days to determine which approaches provide the best balance of clinical benefit and cost. Providers use these results to select operative approaches tailored to patient risk, while payers use them to inform coverage and bundled payment policies for procedures captured in this DRG.
    • Prospective observational and quality-of-life outcomes research following discharge that tracks readmissions, late complications (infection, stricture, chronic pain), return to baseline activities, and patient-reported sexual and urinary function for months to a year after nonmalignant male reproductive O.R. procedures. These studies often include heterogeneous patients with differing CC/MCC profiles to identify predictors of poor post-discharge outcomes and resource use. Results help health systems develop targeted discharge planning and post-acute care interventions and help payers anticipate post-DRG costs associated with readmission risk and long-term functional impairment.

    Related Codes

    707-MAJOR-MALE-PELVIC-PROCEDURES-WITH-CC-MCC

    Major Male Pelvic Procedures with CC/MCC: Inpatient Reimbursement Overview

    708-MAJOR-MALE-PELVIC-PROCEDURES-WITHOUT-CC-MCC

    Major Male Pelvic Procedures without CC/MCC: Inpatient Reimbursement Overview

    709-PENIS-PROCEDURES-WITH-CC-MCC

    Penis Procedures with CC/MCC: Inpatient Reimbursement Overview

    710-PENIS-PROCEDURES-WITHOUT-CC-MCC

    Penis Procedures without CC/MCC: Inpatient Reimbursement Overview

    711-TESTES-PROCEDURES-WITH-CC-MCC

    Testes Procedures with CC/MCC: Inpatient Reimbursement Overview

    712-TESTES-PROCEDURES-WITHOUT-CC-MCC

    Testes Procedures without CC/MCC: Inpatient Reimbursement Overview

    713-TRANSURETHRAL-PROSTATECTOMY-WITH-CC-MCC

    Transurethral Prostatectomy with CC/MCC: Inpatient Reimbursement Overview

    714-TRANSURETHRAL-PROSTATECTOMY-WITHOUT-CC-MCC

    Transurethral Prostatectomy without CC/MCC: Inpatient Reimbursement Overview

    715-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-FOR-MALIGNANCY-WITH-CC-MCC

    Other Male Reproductive System O.R. Procedures for Malignancy with CC/MCC: Inpatient Reimbursement Overview

    716-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-FOR-MALIGNANCY-WITHOUT-CC-MCC

    Other Male Reproductive System O.R. Procedures for Malignancy without CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 20

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.